영어에서 METASTATIC 의 뜻은 무엇인가요?
전이
전이 또는 전이성 질환은 한 기관에서 다른 기관으로 암이 전이되는 것을 말합니다. 이렇게 생성 된 질병의 새로운 발생을 전이 (metastases)라고합니다. 이전에는 악성 종양 세포와 감염 만 전이 할 수있는 능력이 있다고 생각했습니다. 그러나 이것은 새로운 연구로 인해 재고되어야합니다. 기원 전이 란 μετά, 메타, "다음", στάσις, 스타 시스, "배치"에서 "변위"를 의미하는 헬라어 단어입니다. 복수형은 전이 / 증후군이다. 암은 조직의 단일 세포가 점진적으로 유 전적으로 손상되어 통제되지 않은 증식을 가진 세포를 생성 한 후에 발생합니다. 이 조절되지 않은 증식, 유사 분열은 1 차 이종 종양을 생성합니다. 종양을 구성하는 세포는 결국 은형성을 겪고,이어서 발육 부전 및 발육 부전이 나타나 악성 표현형을 낳습니다. 이 악성 종양은 순환계로의 침입을 허용하고, 종양 형성을위한 제 2 부위로의 침범을 일으킨다.
영어 사전에서 metastatic 의 정의
사전에서 전이의 정의는 신체의 한 부분에서 다른 부분으로 질병, 특히 암세포의 확산과 관련된 것입니다. 전이의 다른 정의는 수사학에서와 같이 한 지점에서 다른 지점으로의 변형 또는 변화 또는 관련이 있습니다.
«METASTATIC» 단어가 포함된 영어 인용문
metastatic 단어가 포함된 유명한 인용문 및 문장입니다.
Diagnosed incidentally with stage IV, grade 4 metastatic renal cell carcinoma, I had bone metastases in my femur (which eventually fractured), ulna, and cranium; five metastases in my lungs; and muscle metastases in my thigh and tongue. Yet six months after diagnosis, my treatment ended: I've not had a drop of anything since.
«METASTATIC» 관련 영어 책
다음 도서 목록 항목에서
metastatic 의 용법을 확인하세요.
metastatic 에 관련된 책과 해당 책의 짧은 발췌문을 통해 영어 서적에서 단어가 사용되는 맥락을 제공합니다.
1
100 Questions & Answers About Advanced &
Metastatic Breast ...
Written by experts from Johns Hopkins University and Medical Center, this new edition is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease.
Lillie D. Shockney, Gary R. Shapiro,
2011
2
Metastatic Carcinomas of Unknown Origin
This unique text provides a framework for approaching these complex issues, with contributions from international experts in the field of MCUOs.
3
Advanced breast cancer: a guide to living with
metastatic ...
Newly updated and revised, this is the only book on breast cancer that deals honestly with the realities of metastatic disease, yet offers hope and comfort.All aspects of dealing with the disease are covered, including: Coping with the ...
4
Epithelial Cadherin Re-expression in
Metastatic Breast ...
Epithelial-cadherin downregulation enables cancer cells to escape from the primary mass; however, E-cadherin has been found to be expressed on metastatic foci, bringing into question the role of this molecule in tumor progression.
Christopher Reed Shepard,
2007
5
From Local Invasion to
Metastatic Cancer: Involvement of ...
Specifically, the book presents important developments in the biology and clinical understanding of cancer metastasis, describes the relationship between tumor microenvironment and proliferation, and defines the process of lymphangiogenesis ...
Stanley P. L. Leong,
2009
6
Liver-Directed Therapy for Primary and
Metastatic Liver Tumors
Because of the unique and comprehensive examination of liver tumors, this work is an excellent resource for surgical, transplant and medical oncologists, surgeons, gastroenterologists, and radiologists.
Mark S. Talamonti, Sam G. Pappas,
2001
7
TxNxM1: The Anatomy and Clinics of
Metastatic Cancer
Only risk factors, treatment possibilities, and survival results are extensively examined. Stimulated by the occurrence in his practice of some puzzling and unexpected metastases, the author reviewed more than 12,000 references.
8
Handbook of
Metastatic Breast Cancer
One convenient source bringing together the various relevant aspects is long overdue. This handbook covers treatment for both the cancer and the complications that can arise from treatment itself.
Charles Swanton, Stephen Johnston, Stephen R. D. Johnston,
2006
9
Metastatic Melanoma: New Insights for the Healthcare ...
“Using a large national claims database, this study investigates the differences in
survival and healthcare costs of metastatic melanoma patients by the number of
metastatic sites. An analysis was carried out using data obtained from January ...
10
Factors Affecting Treatment Choice in HER2 Positive ...
The second outcome evaluated was the time to start of treatment (in days).
«METASTATIC» 단어를 포함하는 뉴스 기사
다음 뉴스 기사의 맥락에서 국내 및 국제 언론이 말하는 내용 및
metastatic 단어를 사용하는 방법을 알아보세요.
ASCO guidelines: biomarker use in metastatic breast CA treatment
Biomarkers can be used to guide decisions on systemic therapy for women with metastatic breast cancer, according to the American Society of ... «Medical Xpress, 7월 15»
BioMarin provides programme update for talazoparib in metastatic …
The ABRAZO study includes two cohorts of patients with BRCA mutated metastatic breast cancer. The first cohort consists of patients who have ... «European Pharmaceutical Review, 7월 15»
EC approves nivolumab for patients with previously-treated …
The European Commission has approved Bristol-Myers Squibb's nivolumab for the treatment of locally advanced or metastatic squamous (SQ) ... «European Pharmaceutical Review, 7월 15»
Mom with Stage 4 metastatic breast cancer writes cards for daughter …
MADISON, Wisc. — A 35-year-old mom is making sure her daughter always has motherly support even after she's gone. Heather McManamy ... «fox4kc.com, 7월 15»
BioMarin Provides Program Update for Talazoparib in Metastatic …
The ABRAZO study includes two cohorts of patients with BRCA mutated metastatic breast cancer. The first cohort consists of patients who have ... «Nasdaq, 7월 15»
PI3K inhibitor treatment alone may lead to aggressive, metastatic …
Treatment with PI3K inhibitors alone may actually make a patient's cancer even worse by promoting more aggressive tumor cell behavior and ... «Oncology Nurse Advisor, 7월 15»
Metastatic spinal cord compression surgery may alleviate pain and …
Surgery for metastatic spinal cord compression decreased pain scores and improved patients' autonomy and was associated with limited ... «Healio, 7월 15»
Metastatic Lung Cancer Treatment Gets FDA Nod Of Approval
On Monday, FDA has greenlighted Iressa (gefitinib) as treatment for patients with metastatic NSCLC characterized by certain EGFR gene ... «Tech Times, 7월 15»
Cancer Patients Start Protest Group Like ACT UP
A small but growing group of women with metastatic breast cancer and their supporters have formed MET UP, an activist group modelled on the ... «Medscape, 7월 15»
FDA Approves Gefitinib for Metastatic NSCLC
The FDA has approved gefitinib (Iressa, AstraZeneca/Teva) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) ... «Clinical Oncology News, 7월 15»